 SAN FRANCISCO, March 17, 2021 GLOBE NEWSWIRE -- Olema Pharmaceuticals, Inc. Olema or Olema Oncology, NASDAQ: OLMA, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for womens cancers, today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided a business update. 